NDC 0002-3233-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-3233
- Requested NDC
- 0002-3233-01
- Package NDCs from labels
- 0002-3233-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-11 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-3233-01 | EA - Each | 0002-3233 | a1a40876-81b2-4d1b-ac9f-5ea7ff8f9c6e | 1 | 2013-02-11 |
| 0002-3233-30 | EA - Each | 0002-3233 | 4f610fcf-b8fb-4971-947a-5180e798ea92 | 1 | 2012-07-24 |
| 0002-3233-33 | EA - Each | 0002-3233 | 59932593-2657-4558-a765-db58b745f9a8 | 1 | 2013-02-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Modavar Pharmaceuticals LLC | f0943b4e-6bdc-48c1-8ecd-39cf732e16f5 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | RADHA PHARMACEUTICALS, INC. | 1a07ebe9-3661-4a48-b8af-9b228875166a | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Olanzapine | OLANZAPINE | XGen Pharmaceuticals DJB, Inc. | 3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Strides Pharma Science Limited | 979c3212-36e8-4287-aace-bef0875188d7 | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | 76a6ff21-7157-4213-8073-35837a3ac07e | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine Intramuscular | OLANZAPINE | UBI Pharma Inc. | 6a279fe1-ed99-4a62-b2c7-831961470fa9 | 2026-03-23 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Bryant Ranch Prepack | 3ccada47-7eb9-285d-5059-06afb4466114 | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Bryant Ranch Prepack | bb06af33-8ff7-0b02-0029-d628f62e1382 | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Bryant Ranch Prepack | 77d5c10a-0cfc-4b89-942c-0fb5c67ae409 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Olanzapine | OLANZAPINE | HEC Pharm USA Inc. | 4d1b83db-54db-d51f-e063-6394a90a4a69 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| OLANZAPINE | OLANZAPINE | HEC Pharm USA Inc. | 4d34f8f3-edc8-0a68-e063-6394a90a9c1f | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Dr.Reddy's Laboratories Limited | aff02cff-d079-bc82-6182-a24c4c6e09a6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Inc. | d474d5a9-d338-511d-5823-567c0a1bbf4d | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Anthea Pharma Private Limited | e6ffcc56-63f9-4b12-a07a-c6177ffef5e8 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| JAYPIRCA | PIRTOBRUTINIB | Eli Lilly and Company | bd551845-0878-49a4-860f-839b83f6b801 | 2026-03-06 | Warnings, Adverse reactions | Eli Lilly and Company |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | 8e095987-bdea-42f2-9550-c7155cf07d30 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | df43938a-3469-40eb-8166-f0a2fd29d6d8 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Torrent Pharmaceuticals Limited | 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | American Regent, Inc. | e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.